Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.205 AUD | -2.38% |
|
-6.82% | -39.71% |
May. 03 | Transcript : Next Science Limited - Shareholder/Analyst Call | |
Apr. 24 | Next Science Product Sales Rise 19% to $5.5 Million for March Quarter | MT |
Business Summary
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bacterial Related Issues Technologies
100.0
%
| 17 | 100.0 % | 33 | 100.0 % | +97.77% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
North America
98.5
%
| 16 | 94.0 % | 33 | 98.5 % | +107.15% |
Australia and New Zealand
1.5
%
| 1 | 6.0 % | 1 | 1.5 % | -49.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Matthew Myntti
FOU | Founder | - | 17-10-19 |
Harry Hall
CEO | Chief Executive Officer | - | 23-07-09 |
Marc Zimmerman
DFI | Director of Finance/CFO | - | 23-05-25 |
Jeanne Lee
CTO | Chief Tech/Sci/R&D Officer | - | 19-02-28 |
Jon Swanson
COO | Chief Operating Officer | - | 18-05-31 |
Françoise Dixon
IRC | Investor Relations Contact | - | - |
Michael Morello
PRN | Corporate Officer/Principal | - | 21-03-31 |
Corporate Secretary | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Hall
CEO | Chief Executive Officer | - | 23-07-09 |
Grant Hummel
BRD | Director/Board Member | - | 23-08-22 |
Chairman | 62 | 18-09-30 | |
Katherine Ostin
BRD | Director/Board Member | - | 23-10-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 291,695,103 | 136,073,909 ( 46.65 %) | 0 | 46.65 % |
Company contact information
![address Next Science Limited(NXS)](https://cdn.zonebourse.com/static/address/55886808.png)
Sector
Sales per region
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-39.71% | 41.31M | |
+59.97% | 827B | |
+38.38% | 634B | |
-6.18% | 350B | |
+15.61% | 319B | |
+8.44% | 294B | |
+12.68% | 240B | |
+14.40% | 221B | |
+0.04% | 219B | |
+9.68% | 167B |
- Stock Market
- Equities
- NXS Stock
- Company Next Science Limited